ストックスクリーナーアプリを入手
1.56
2.63%
0.04
プレマーケット:
1.54
-0.02
-1.28%
前日終値:
$1.52
開ける：
$1.57
24時間の取引高:
5.16M
Relative Volume:
0.71
時価総額：
$470.98M
収益：
$188.87M
当期純損益:
$-400.38M
株価収益率:
-1.04
EPS:
-1.5
ネットキャッシュフロー:
$-260.90M
1週間 パフォーマンス:
-4.29%
1か月 パフォーマンス:
-20.00%
6か月 パフォーマンス:
+25.81%
1年 パフォーマンス:
+15.56%
1日の値動き範囲:
$1.545
$1.65
1週間の範囲:
$1.49
$1.80
52週間の値動き範囲:
$0.8511
$2.73
Pacific Biosciences Of California Inc Stock (PACB) Company Profile
名前
Pacific Biosciences Of California Inc
セクター
電話
650-521-8000
住所
1305 O'BRIEN DRIVE, MENLO PARK, CA
Compare PACB vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PACB
Pacific Biosciences Of California Inc
|
1.56 | 458.90M | 188.87M | -400.38M | -260.90M | -1.50 |
|
ABT
Abbott Laboratories
|
113.10 | 197.42B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
381.89 | 147.18B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
95.60 | 124.16B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
72.21 | 109.58B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
85.22 | 49.49B | 6.07B | 1.06B | 1.34B | 1.8063 |
Pacific Biosciences Of California Inc Stock (PACB) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-11-11 | ダウングレード | UBS | Buy → Neutral |
| 2024-06-03 | 再開されました | Jefferies | Buy |
| 2024-04-22 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2024-04-18 | ダウングレード | Goldman | Buy → Neutral |
| 2023-12-14 | 開始されました | Guggenheim | Neutral |
| 2023-12-14 | 開始されました | Stephens | Overweight |
| 2023-12-13 | 開始されました | Wolfe Research | Peer Perform |
| 2023-11-17 | アップグレード | UBS | Neutral → Buy |
| 2023-10-31 | アップグレード | Cantor Fitzgerald | Neutral → Overweight |
| 2023-09-28 | 開始されました | Bernstein | Outperform |
| 2023-07-05 | 再開されました | JP Morgan | Overweight |
| 2023-06-30 | 開始されました | Goldman | Buy |
| 2023-05-10 | 開始されました | Barclays | Equal Weight |
| 2023-03-31 | アップグレード | TD Cowen | Market Perform → Outperform |
| 2023-02-02 | 開始されました | UBS | Neutral |
| 2023-01-20 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2023-01-05 | 開始されました | Scotiabank | Sector Outperform |
| 2022-01-21 | 再開されました | Cantor Fitzgerald | Overweight |
| 2022-01-06 | 再開されました | Piper Sandler | Neutral |
| 2021-10-15 | 再開されました | Cowen | Market Perform |
| 2021-09-27 | 開始されました | Canaccord Genuity | Buy |
| 2021-02-11 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2020-11-03 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2020-10-02 | アップグレード | JP Morgan | Neutral → Overweight |
| 2020-09-09 | 開始されました | Morgan Stanley | Equal-Weight |
| 2020-06-02 | 再開されました | Cantor Fitzgerald | Overweight |
| 2020-03-09 | 再開されました | Cantor Fitzgerald | Overweight |
| 2019-10-15 | アップグレード | Piper Jaffray | Neutral → Overweight |
| 2019-04-02 | ダウングレード | Stephens | Overweight → Equal-Weight |
| 2018-10-19 | 開始されました | Cowen | Outperform |
| 2017-11-03 | ダウングレード | First Analysis Sec | Overweight → Equal-Weight |
| 2017-09-28 | ダウングレード | CL King | Buy → Neutral |
| 2016-11-03 | 繰り返されました | Cantor Fitzgerald | Buy |
| 2016-06-27 | 開始されました | CL King | Buy |
| 2016-04-15 | 開始されました | First Analysis Sec | Overweight |
| 2016-02-04 | ダウングレード | Piper Jaffray | Overweight → Neutral |
| 2016-01-04 | 繰り返されました | Cantor Fitzgerald | Buy |
| 2015-10-23 | アップグレード | Piper Jaffray | Neutral → Overweight |
| 2015-08-27 | 開始されました | Cantor Fitzgerald | Buy |
| 2015-02-04 | 繰り返されました | Maxim Group | Buy |
| 2013-09-26 | 繰り返されました | Maxim Group | Buy |
| 2013-01-14 | 繰り返されました | Maxim Group | Buy |
すべてを表示
Pacific Biosciences Of California Inc (PACB) 最新ニュース
Pacific Biosciences of California, Inc. $PACB Shares Sold by ARK Investment Management LLC - MarketBeat
Farmer Michele sells Pacific Biosciences (PACB) shares for $4510 - Investing.com India
Pacific Biosciences of California (NASDAQ:PACB) Insider Christian Henry Sells 12,497 Shares - MarketBeat
PRISM 2026 set to shape genomics future, Pacific Biosciences of California asserts - Traders Union
PACB,TAL Volatility & Greeks - Finviz
Here's Why You Should Retain Revvity Stock in Your Portfolio for Now - Finviz
Intuitive Surgical Expands Direct Operational Presence in Europe - Finviz
Life Sciences Tools & Services Stocks Q4 Recap: Benchmarking PacBio (NASDAQ:PACB) - Finviz
Equity awards to Pacific Biosciences (PACB) officer disclosed - Stock Titan
PACB (PACB) grants James R. Gibson II 667,696 options and 333,848 RSUs - Stock Titan
Pacific Biosciences (PACB) officer receives large option and RSU awards - Stock Titan
Large equity grants to PacBio (PACB) executive highlight retention focus - Stock Titan
Christian Henry sells 472,667 PACB shares (PACB) on Form 144 - Stock Titan
PacBio and DNAstack Join Forces to Launch Worldwide HiFi Genome Network Hub - Bitget
PacBio and DNAstack Collaborate on Global HiFi Genome Network Hub - Yahoo Finance
Pacific Biosciences of California enables automatic epigenetic data in HiFi sequencing runs - Traders Union
Pacific Biosciences of California backs San Diego event to strengthen rare disease awareness - Traders Union
PacBio, Myriad Genetics, LeMaitre, Hims & Hers Health, and GoodRx Shares Are Falling, What You Need To Know - Finviz
PACB,TAL Revenue Breakdown - Finviz
Pacific Biosciences of California joins IRDiRC to advance rare disease research - Traders Union
Vestmark Advisory Solutions Inc. Sells 692,663 Shares of Pacific Biosciences of California, Inc. $PACB - MarketBeat
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Pacific Biosciences of California (PACB) Stock Analysis: A 53% Upside Awaits in the Genomic Sequencing Arena - DirectorsTalk Interviews
Pacific Biosciences Of California Files For Mixed Shelf Size - TradingView
[10-K] PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Files Annual Report | PACB SEC FilingForm 10-K - Stock Titan
Why Is PacBio (PACB) Stock Soaring Today - Yahoo Finance
PacBio (PACB) Joins Forces with DNAstack for Global Genomic Data Collaboration - GuruFocus
Volume Recap: Is Pacific Biosciences of California Inc stock a buy or sell2025 Winners & Losers & Free Reliable Trade Execution Plans - baoquankhu1.vn
PacBio and DNAstack launch first global federated HiFi whole genome dataset to accelerate rare disease research - marketscreener.com
Global genome network to speed answers for rare disease patients - Stock Titan
Pacific Biosciences of California examines technology impact on DNA sequencing insights - Traders Union
Pacific Biosciences COO Sells Shares - Intellectia AI
Why The PacBio (PACB) Narrative Is Shifting Around Fair Value And Long Read Sequencing - Yahoo Finance
Pacific Biosciences of California (NASDAQ:PACB) Stock Rating Upgraded by Zacks Research - MarketBeat
Will Pacific Biosciences of California Inc. outperform tech stocksMarket Movers & Weekly Stock Performance Updates - mfd.ru
Pacific Biosciences of California (NASDAQ:PACB) Insider Christian Henry Sells 331,793 Shares - MarketBeat
Van Oene Mark sells PACB shares worth $294,318 By Investing.com - Investing.com Canada
Farmer of Pacific Biosciences sells $79,855 in stock By Investing.com - Investing.com South Africa
Van Oene Mark sells PACB shares worth $294,318 - Investing.com
Farmer of Pacific Biosciences sells $79,855 in stock - Investing.com
5 Must-Read Analyst Questions From PacBio's Q4 Earnings Call - Finviz
PacBio (PACB) Q4 2025 Earnings Call Transcript - AOL.com
PacBio (PACB): Buy, Sell, or Hold Post Q4 Earnings? - Finviz
PacBio stock up on HiFi sequencing adoption for major SUDC research - MSN
PacBio leaders set for TD Cowen health conference webcast - Stock Titan
Pacific Biosciences of California : PACB Q4 2025 Earning Prepared Remarks - marketscreener.com
Exit Recap: Should I invest in Clene Inc before earningsEarnings Risk Summary & Stepwise Swing Trade Plans - baoquankhu1.vn
Pacific Biosciences Faces Turbulent Market Amid Industry Shifts - timothysykes.com
Aug Drivers: Will Pacific Biosciences of California Inc outperform tech stocks2025 EndofYear Setup & Free Community Consensus Stock Picks - baoquankhu1.vn
Is Pacific Biosciences of California Inc. stock a falling knife or bargain buy2025 Stock Rankings & Long Hold Capital Preservation Tips - mfd.ru
How does Pacific Biosciences of California Inc. compare to its peersJuly 2025 Short Interest & Risk Managed Investment Signals - mfd.ru
Pacific Biosciences Of California Inc (PACB) 財務データ
収益
当期純利益
現金流量
EPS
Pacific Biosciences Of California Inc (PACB) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Van Oene Mark | See Remarks |
Mar 03 '26 |
Sale |
1.51 |
6,504 |
9,847 |
2,243,634 |
| Farmer Michele | See Remarks |
Mar 03 '26 |
Sale |
1.51 |
2,979 |
4,510 |
305,948 |
2.27%
1.94%
大文字化:
|
ボリューム (24 時間):